Lab Notes: FDA to review Pfizer's application for gene therapy licensed from Spark Therapeutics

This week's Lab Notes has updates on a Spark-developed gene therapy candidate licensed to Pfizer, a laboratory equipment supplier's new program to benefit the environment, some funding news for two local life sciences companies and more.

Source: bizjournals.com Health Care:Biotechnology headlines - June 30, 2023 Category: Biotechnology Authors: John George Source Type: news